Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFDA approves first immunotherapy combo.AuthorsMullard, AsherAbstractThe article discusses the U.S. Food and Drug Administration's (FDA) approval of Bristol-Myers Squibb's immunotherapy combination drugs nivolumab and ipilimumab as treatment for metastatic melanoma.SubjectsDRUG approval; IMMUNOTHERAPY; UNITED States. Food &; Drug Administration; IPILIMUMAB; METASTASIS; MELANOMA treatmentPublicationNature Reviews Drug Discovery, 2015, Vol 14, Issue 11, p739ISSN1474-1776Publication typejournal articleDOI10.1038/nrd4779